Results 1 to 10 of about 1,901 (123)

Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d’Ivoire [PDF]

Tropical Medicine and Infectious Disease
Seasonal malaria chemoprevention (SMC) is a strategy recommended by the World Health Organization for children aged 3–59 months in the Sahel and sub-Sahel regions where malaria transmission is seasonal.
Issaka Zongo, Alassane Haro, William Yavo   +2 more
exaly   +4 more sources

Status and prospects of seasonal malaria chemoprevention among children in Sahelian countries: A systematic review and meta-analysis. [PDF]

PLOS Global Public Health
In areas with seasonal malaria transmission, seasonal malaria chemoprevention (SMC) involves giving children a three-day course of sulfadoxine-pyrimethamine and amodiaquine once a month during the transmission season.
Medard Djedanem, Noura Mamane Salé, Elhadji Yacoudima Yacoubou Mahaman Aminou, Jean Testa, Ronan Jambou   +4 more
doaj   +2 more sources

Trends in uncomplicated and severe malaria following seasonal malaria chemoprevention administration in Nouna, Burkina Faso: a quasi-experimental pre-post study [PDF]

Malaria Journal
Background While Seasonal Malaria Chemoprevention (SMC) has been adopted as a malaria control strategy in regions with seasonal transmission, continued monitoring and evaluation of its effectiveness across diverse ecological, epidemiological, and ...
Elisabeth A. Gebreegziabher, Mamadou Ouattara, Mamadou Bountogo, Boubacar Coulibaly, Valentin Boudo, Thierry Ouedraogo, Elodie Lebas, Huiyu Hu, David V. Glidden, Benjamin F. Arnold, Thomas M. Lietman, Ali Sié, Catherine E. Oldenburg   +12 more
doaj   +2 more sources

School-aged children based seasonal malaria chemoprevention using artesunate-amodiaquine in Mali

Parasite Epidemiology and Control, 2018
Introduction: Malaria is still a public health problem in Africa. Seasonal Malaria Chemoprevention (SMC) is an efficient control strategy recommended by WHO that targets children under five year old living in areas of seasonal malaria transmission.
Mahamadou A Thera, Abdoulaye K Koné, Mahamadou S Sissoko   +2 more
exaly   +3 more sources

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children

Nature Communications, 2019
Seasonal malaria chemoprevention provides substantial benefit for young children, but resistance to used drugs will likely develop. Here, Chotsiri et al.
Palang Chotsiri, Paul Milligan, Yves Daniel Compaoré   +2 more
exaly   +2 more sources

Emergence of Plasmodium falciparum pfdhps A581G mutation in Southern Senegal under Seasonal Malaria Chemoprevention pressure, 2020-2023 [PDF]

Communications Medicine
Background: Malaria prevention in Senegal includes the use of Seasonal Malaria Chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine. Prolonged use of sulfadoxine-pyrimethamine, however, can select for mutations in the Plasmodium falciparum ...
Mamadou Alpha Diallo, Abdoulaye Tine, Djiby Sow, Aita Sene, Amy Gaye, Yaye D. Ndiaye, Jules Gomis, Baba Dieye, Awa B. Deme, Mamadou S. Yade, Bassirou Ngom, Mamane N. Garba, Ibrahima M. Ndiaye, Khadim Diongue, Aida Sadikh Badiane, Mame Cheikh Seck, Mouhamadou Ndiaye, Daouda Ndiaye   +17 more
doaj   +2 more sources

Seasonal Malaria Chemoprevention Implementation: Effect on Malaria Incidence and Immunity in a Context of Expansion of P. falciparum Resistant Genotypes with Potential Reduction of the Effectiveness in Sub-Saharan Africa

Infection and Drug Resistance, 2022
Séni Nikiema,1,2 Issiaka Soulama,1,3 Salif Sombié,1 André-Marie Tchouatieu,4 Samuel Sindie Sermé,5 Noëlie Béré Henry,5 Nicolas Ouedraogo,1 Nathalie Ouaré,1,6 Raissa Ily,1,6 Oumarou Ouédraogo,3 Dramane Zongo,3 Florencia Wendkuuni Djigma,2 Alfred B Tiono,1
Seni Nikiema, Issiaka Soulama, Salif Sombie   +2 more
exaly   +2 more sources

Impact of seasonal malaria chemoprevention based on the number of medicines doses received on malaria burden among children aged 3–59 months in Nigeria: A propensity score‐matched analysis

Tropical Medicine and International Health
Abstract Background Seasonal malaria chemoprevention using sulfadoxine‐pyrimethamine plus amodiaquine (sulfadoxine‐pyrimethamine plus amodiaquine on Day 1 and amodiaquine on both Day 2 and Day 3) is delivered to children aged 3–59 months in areas of highly season malaria transmission.
Kevin Baker, Taiwo Ibinaiye, Olusola Oresanya   +2 more
exaly   +2 more sources

Evaluating the effectiveness and cost-effectiveness of integrating mass drug administration for helminth control with seasonal malaria chemoprevention in Ghanaian children: Protocol for a cluster randomised controlled trial. [PDF]

Trop Med Int Health
Abstract Objectives To evaluate the effectiveness and cost‐effectiveness of integrating seasonal malaria chemoprevention (SMC) with mass drug administration for helminth control among school‐aged children living in communities where the burden of malaria and helminths is high in Ghana, West Africa.
Afolabi MO, Adu-Gyasi D, Paintain L, Tawiah T, Ali MS, Greenwood B, Asante KP.   +6 more
europepmc   +2 more sources

Seasonal malaria chemoprevention in northern Mozambique: a cost-effectiveness analysis [PDF]

Malaria Journal
Background Malaria is endemic in Mozambique and one of the leading causes of death in children under 5 years old. In 2020 the country adopted the WHO-recommended seasonal malaria chemoprevention (SMC) strategy and delivered the intervention in all 23 ...
Neide Canana, Ivan Alejandro Pulido Tarquino, Sónia Enosse, Kevin Baker, Maria Rodrigues, Christian Rassi, Akashdeep Singh Chauhan, Chuks Nnaji, Baltazar Candrinho, Elisa M. Maffioli   +9 more
doaj   +2 more sources